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Purpose
To evaluate the utility and prognostic value of delayed
enhancement and T2 weighted cardiovascular MRI in
patients at high risk for cardiac sarcoidosis.
Introduction
The utility of delayed-enhancement (DE) has been
extensively studied in patients with sarcoidosis who are
asymptomatic or at low risk for cardiac involvement.
However, there is lack of data regarding the utility of
DE in patients with sarcoidosis who present with high
grade cardiovascular symptoms. Also, the utility of
T2-weighted imaging has not been evaluated in these
patients.
Methods
Patients referred for cardiac MRI (CMR) from 01/01/
2003 to 12/31/2009 in our institution, and who had
biopsy proven sarcoidosis without concomitant coronary
artery disease, were included. Patients were classified as
presenting with a major rhythmic disturbance (MRD) if
the referral for cardiac MRI was prompted by high
grade atrio-ventricular block, sustained ventricular
tachycardia or ventricular fibrillation. Mean duration of
follow up after MRI was 20.7 +13.8 months.
Results
Forty patients with sarcoidosis referred for CMR met
entry criteria. 8/40 (20%) patients experienced a MRD
p r i o rt oC M R .O ft h e s e ,8 / 8( 1 0 0 % )p a t i e n t sd e m o n -
strated hyper-enhancement and 4/8 (50%) had hyper-
intensity on T2W-CMR. During follow-up, 8/8 (100%)
had recurrent MRD or required permanent pacemaker
implantation. DE of a patient presenting with com-
plete heart block is shown in Figure 1. In the 32/40
(80%) patients without an MRD prior to MRI, 11
(34%) demonstrated hyperenhancement on DE-MRI.
From these, 3/11 (27%) also had hyper-intensity on
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Figure 1 Delayed-enhancement of a patient presenting with
complete heart block.
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out a prior MRD and no delayed enhancement, T2W-
CMR was negative in all cases. None of these
21 patients had a MRD during follow-up.
Conclusions
In patients with suspected cardiac sarcoidosis who pre-
sent with a MRD, DE-CMR is extremely likely to be
positive and is helpful in confirming cardiac involve-
ment. These patients are highly likely to experience
recurrent adverse events regardless of the presence or
absence of acute edema or inflammation on MRI.
Patients without a prior MRD who show no evidence of
delayed enhancement by CMR have an excellent prog-
nosis and are at very low risk of developing a MRD
within next year. A history of a prior MRD is the stron-
gest predictor of a future MRD. CMR, however, has a
valuable role to play in confirming the diagnosis and
refining risk, particularly in those presenting without
a prior MRD.
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